|
Market Cap (25-Jun) $7,649,007 (1,598th) |
Close (30-Jun) $0.024 |
Volume (30-Jun) 2,170,184 |
Shortsold (2-Feb) 3,141 (0.00%) (662nd) |
|
52w High $0.008 |
52w Low $0.002 |
P/E - |
EPS 0 |
1AD released this announcement to the ASX on 24 May 2021, 8:44. The announcement is marked as price sensitive, and is 3 page(s) in length and 359.22kb in size.
You can view all announcements from 1AD and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from 1AD | |
|---|---|
| AD-214 clinical trial approval | 29 June 2023, 8:21 |
| Change in substantial holding | 31 May 2023, 13:30 |
| Change in substantial holding | 31 May 2023, 9:34 |
| GE Healthcare collaboration advances to next stage | 24 May 2021, 8:44 |
| AdAlta granted Japanese patent for AD-214 | 19 May 2021, 9:15 |
| CSO presentation at ILD Drug Development Summit | 28 April 2021, 17:24 |
| Quarterly Appendix 4C and Activities Report | 20 April 2021, 8:28 |
You must be logged in to post a reply.
AdAlta 